PARADIGM MEDICAL INDUSTRIES, INC.
                              2355 South 1070 West
                           Salt Lake City, Utah 84119
                                 (801) 977-8970




                                                 January 11, 2005





VIA EDGAR
---------

Securities and Exchange Commission
450 Fifth Street, N.W.
Judicial Plaza
Washington, D.C. 20549

Attn:    Thomas A. Jones
         Senior Attorney

         Re:  Paradigm Medical Industries, Inc.
              Application for Withdrawal of Registration Statement on Form SB-2
              Commission File No. 333-103061

Ladies and Gentlemen:

         Paradigm  Medical  Industries,   Inc.,  a  Delaware   corporation  (the
"Registrant"),  hereby requests pursuant to Rule 477(a) of the Securities Act of
1933, as amended, that the Securities and Exchange Commission (the "Commission")
consent  to  the  withdrawal  of  the  Registrant's   Amendment  No.  1  to  the
Registration  Statement No.  333-103061,  which was filed with the Commission on
December 22, 2004, on Form SB-2,  together with any exhibits  filed thereto (the
"Amendment").

         The Amendment was filed as a pre-effective rather than a post-effective
amendment  to the  Registration  Statement  to  register  for  resale  shares of
Registrant's   common  stock  for  certain   shareholders,   optionholders   and
warrantholders.  For this reason,  Registrant requests for the withdrawal of the
Amendment.  No securities of  Registrant  have been sold in connection  with the
filing of the Amendment.  Registrant intends to amend the Registration Statement
by filing a post- effective amendment on Form SB-2.

         Please  direct any questions or comments  regarding  this filing to the
undersigned at (801) 977-8970 or Randall A. Mackey, Esq. at (801) 575-5000.

                                       PARADIGM MEDICAL INDUSTRIES, INC.



                                       By: /s/ John Y. Yoon  
                                          --------------------------------------
                                           John Y. Yoon
                                           President and Chief Executive Officer